000 01284 a2200361 4500
005 20250516054129.0
264 0 _c20111101
008 201111s 0 0 eng d
022 _a0392-856X
040 _aNLM
_beng
_cNLM
100 1 _aTodoerti, Monica
245 0 0 _aRecommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label use.
_h[electronic resource]
260 _bClinical and experimental rheumatology
_c
300 _aS42-62 p.
_bdigital
500 _aPublication Type: Journal Article; Practice Guideline; Review
650 0 4 _aBiological Products
_xtherapeutic use
650 0 4 _aBiological Therapy
_xstandards
650 0 4 _aEvidence-Based Medicine
_xstandards
650 0 4 _aHumans
650 0 4 _aInflammation
_xtherapy
650 0 4 _aItaly
650 0 4 _aOff-Label Use
_xstandards
650 0 4 _aPatient Selection
650 0 4 _aRheumatic Diseases
_xtherapy
650 0 4 _aRheumatology
_xstandards
650 0 4 _aSocieties, Medical
_xstandards
650 0 4 _aTreatment Outcome
700 1 _aPipitone, Nicolo'
700 1 _aMatucci-Cerinic, Marco
700 1 _aMontecucco, Carlomaurizio
700 1 _aCaporali, Roberto
773 0 _tClinical and experimental rheumatology
_gvol. 29
_gno. 3 Suppl 66
_gp. S42-62
999 _c21146406
_d21146406